StockWatch
·

Boston Bio Systems Ltd

BSE: 531458

P/L Snapshot

Q3 FY26 · standalone

vs Q2 FY26
Revenue
0.06
-75.9%
Expenditure
0.07
-62.0%
Net Profit
-0.01
-135.5%
OPM %
—

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-0.63-0.270.100.460.82Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Price Chart
Latest News

Corporate Events

Board MeetingBOSTON
2026
15Nov

Board Meeting

The Board of Directors will consider and approve the Unaudit…

BSE Filing ↗
Board MeetingBOSTON
2026
30Sep

Board Meeting

The Annual General Meeting ("AGM") of the Members of Boston …

BSE Filing ↗
Board MeetingBOSTON
2026
11Sep

Board Meeting

The Board of Directors considered and approved the Audited F…

BSE Filing ↗
Board MeetingBOSTON
2026
14Aug

Board Meeting

A meeting of the Board of Directors of Boston Commerce Limit…

BSE Filing ↗
Board MeetingBOSTON
2026
5Aug

Board Meeting

The Extra-ordinary General Meeting of the Company will be he…

BSE Filing ↗
Board MeetingBOSTON
2026
7Jul

Board Meeting

The board meeting is scheduled to consider and approve the r…

BSE Filing ↗
Board MeetingBOSTON
2026
30May

Board Meeting

The board meeting is scheduled to consider and approve the A…

BSE Filing ↗
Board MeetingBOSTON
2025
1Oct

Board Meeting

Closure of trading window for the quarter ending 30th Septem…

BSE Filing ↗
Board MeetingBOSTON
2025
14Aug

Board Meeting

Consider and approve Unaudited Financial Results of the Comp…

BSE Filing ↗
Board MeetingBOSTON
2025
14Feb

Board Meeting

Consider and approve unaudited Financial Results of the Comp…

BSE Filing ↗
Board MeetingBOSTON
2024
14Nov

Board Meeting

Intimation Of Board Meeting, Consider and approve unaudited …

BSE Filing ↗
Board MeetingBOSTON
2024
6Sep

Board Meeting

Outcome Of Board Meeting

BSE Filing ↗
Board MeetingBOSTON
2024
13Aug

Board Meeting

consider and approve the Standalone Unaudited Financial Resu…

BSE Filing ↗